2024
Prevalence of Underreported Nicotine Exposure Among US Nonsmoking Adults: A Comparison of Self-Reported Exposure and Serum Cotinine Levels From NHANES 2013–2020
Nicotine and Tobacco Research
Publisher's siteUpdate your location to show providers, locations, and services closest to you.
Cancer Specialist (Oncologist)
Christopher R. Cogle, M.D. is a physician and scientist with research focus on cancer and health policy. In his early career Dr. Cogle discovered that blood stem cells make blood vessels and used that biology to invent new therapeutics and diagnostics for people with cancer and heart disease. In his mid career, as a Leukemia & Lymphoma Society Scholar in Clinical Research, he translated laboratory research discoveries into investigator-initiated clinical trials. Dr. Cogle has also made major discoveries in cancer epidemiology and was elected to lead Florida’s cancer prevention and control efforts at the state level, producing the Florida Cancer Plan, leading statewide campaigns for improved cancer prevention and control, and advising the Florida Legislature, Florida Secretary of Health, and Florida Governor on evidence-based strategies to reduce the state's cancer burden. In 2020, Dr. Cogle was selected by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar. In 2021, Dr.Cogle founded the Florida Health Policy Leadership Academy at the Bob Graham Center for Public Service. His academy team of faculty trains Florida's community leaders in promoting health and preventing disease and disease progression for Florida's 21 million residents and 100 million visitors. In 2023, he was selected by the Milbank Memorial Foundation as a state health policy fellow.
168 publications
2024
Nicotine and Tobacco Research
Publisher's site2023
Obstetrics and gynecology
PubMed • Publisher's site2023
Contemporary clinical trials
PubMed • Publisher's site2023
Cancer
PubMed • Publisher's site2023
Blood Advances
PubMed • Publisher's site